Vape Calibration: How to Actually Measure Your Nicotine Load

Most vape users at intake can tell me the brand, the colour, the flavour, and roughly when they reach for it. They can tell me which drawer the spare is in. They can tell me the day the device started feeling less satisfying. The one thing they almost never know is the actual daily dose — the number in milligrams that decides whether a 14mg patch is going to undertreat them by half, and whether a 21mg patch with breakthrough lozenges is going to settle the first week or barely touch it.

This is the part that almost every public-health quit programme has not yet calibrated. The pharmacy dose conversation runs on numbers. How many cigarettes a day is the question that converts to a patch strength on the back of the leaflet. A vape user who answers I don't really know, I just hit it whenever ends up on whichever patch the pharmacist picks by gut, and undersedation in week one is the most reliable reason a vape quit attempt collapses on Day 5 rather than holding through the Wall.

This article is the workshop for closing that gap. Four numbers. Three worked examples. One conversation to have at the pharmacy counter that you can actually win. The behavioural side of a vape quit is in the longer Quitting Vapes guide; this is the dose-arithmetic companion to it.

The four numbers you need

You need four things to estimate your daily nicotine load. Three of them are printed on the device or the box. The fourth is the one most users miss.

1. Nicotine concentration (mg/mL). Printed on the side of every legal device sold in most jurisdictions. Disposable pods usually say 5% (which is 50 mg/mL), 3% (30 mg/mL), or 2% (20 mg/mL). Open tank bottles run lower, often 3 mg/mL to 12 mg/mL. The percentage shorthand is what trips most users — 5% is not 5 mg, it is 50 milligrams of nicotine per millilitre of liquid.
2. Volume per day (mL). For a disposable, this is the pod size (commonly 2 mL in the UK and Malaysia, 5 to 8 mL elsewhere) multiplied by how many devices you finish per day or per week. For a pod system, the cartridge volume (usually 0.7 to 2 mL) multiplied by refills per day. For an open tank, the tank capacity multiplied by refills.
3. How long one device or bottle actually lasts you. This is the number most users overestimate. One disposable lasts me three or four days in conversation is, in practice, often one and a half. Track for one week before you do the math, not from memory.
4. The bioavailability factor. The nicotine in the liquid is not all the nicotine in your bloodstream. Roughly 25 to 35 percent of the nicotine in the aerosol is systemically absorbed for most modern devices, depending on inhalation depth, breath-hold, and device type. For the back-of-envelope calculation, use 30 percent. A cigarette by comparison delivers roughly 70 to 80 percent of its labelled content systemically, which is part of why the cigarette-equivalent conversion misleads.

With those four numbers, the calculation is one line:

Daily systemic nicotine (mg) = Concentration (mg/mL) × Volume per day (mL) × 0.30

Three worked examples

The same arithmetic applied to the three device classes most quitters arrive with.

The puff-count alternative

When the refill data is not reliable — the device is borrowed, the pods come pre-filled with unclear volumes, or the user genuinely cannot remember how many they finished last week — the puff count is the fallback.

Most modern disposables advertise a puff count on the box: 600, 3500, 6000. A 600-puff disposable at 5% nicotine delivers roughly 20 mg of systemic nicotine over its lifetime (the advertised number is generous; assume the device actually lasts 80 percent of the label). If you finish one a day, you are at roughly the packet-a-day equivalent. If you finish a 3500-puff device in two days, you are at roughly twice that.

The honest version of this question is harder than the user expects: how many days, on average, does one device last you, not how often do you replace it. Track for seven days. Write it down. Bring the number to the pharmacy.

What to do with the number

Three operational uses for the estimate.

1. The combination-NRT decision. Below roughly 15 mg per day, a single short-acting form (gum or lozenge) used responsively may be enough. Between roughly 15 and 30 mg per day, the published evidence supports a 14 to 21mg patch with short-acting backup for breakthrough cravings. Above 30 mg per day, the conversation is about a 21mg patch with consistent short-acting use, sometimes a second patch or a higher-dose product depending on local availability, and a step-down schedule that runs ten to twelve weeks rather than the standard four to six. The dose belongs to the pharmacist or GP; the estimate belongs to you.
2. The step-down planning. A vape quitter who reports being on roughly 60 mg per day going into the quit cannot reasonably step down to no NRT in four weeks. The receptor is reset by Day 21 but the behavioural pattern usually takes eight to twelve weeks to replace, and an aggressive step-down is the second-most-common cause of week-six relapse (the first is no behavioural plan at all). The starting load shapes the timeline.
3. The expectation setting on Day 3. Knowing your load gives you a defensible reason for what Day 3 is going to feel like. The user pulling 90 mg per day from an imported 6 mL disposable is going to have a different first 72 hours than the user pulling 4 mg per day from a low-concentration open tank, and both deserve to be told that in advance. The withdrawal timeline applies to both, but the intensity scales with the load.

Common errors in the calculation

Five places the math goes wrong, in rough order of how often I see them.

• Counting puffs instead of dose. Puff volume varies by three or four times between users. A long, deep pull on a subohm tank delivers more nicotine than a short pull on a closed disposable, even at the same labelled concentration. The mL-based calculation is the more reliable of the two; the puff count is a fallback when mL data is missing.
• Treating I only vape socially as low load. A 5% disposable finished over a long weekend is not a light habit. The session intensity matters less than the cumulative weekly volume for NRT planning.
• Forgetting the morning hits. Most heavy vapers take the first ten to twenty puffs of the day in the first thirty minutes after waking, and those puffs are pharmacologically heavier than the ones spread across the afternoon because the overnight receptor downregulation is already a craving. They count, and they bias the daily estimate upward if the user is keeping a real log instead of guessing from memory.
• Confusing percentage and milligrams. 5% is 50 mg/mL, not 5 mg/mL. The off-by-ten error here is the single most common calculation mistake I see in clinic. If a number looks suspiciously low (a 5% disposable user calculating themselves at 3 mg systemic per day), check the unit conversion first.
• Assuming the device delivers what the label says. The 600-puff and 3500-puff labels are best-case manufacturer claims under laboratory inhalation conditions, and real-world device life is shorter by roughly 20 percent. The user who says one disposable lasts me four days is often using one every two and a half. Track honestly for a week before you trust the number.

What this isn't

This is not a substitute for the prescriber. The actual NRT decision — whether to use a patch, what strength, whether to combine, how to step down, whether varenicline is a better fit for your case, what to do about side effects — belongs to your pharmacist or GP. The estimate this article gives you is the input to that conversation, the number that lets you bring something more useful than I just vape whenever into the room. The clinician still owns the dose.

It is also not a substitute for the behavioural work. Knowing your load tells you what week one needs to look like pharmacologically. It does not tell you what to do when the device is on the bedside table the morning of quit day, or when your hand reaches for the pocket every time you pick up the phone. That work is the trigger map for a vape quit and is the load-bearing piece by week three.

A good quit plan is not the one with the most accurate dose. It is the one where the dose, the trigger map, and the identity work are all calibrated to the same person.

A note on the numbers: bioavailability for modern vape aerosols is an active research area, and the 30 percent figure is a working clinical estimate rather than a fixed constant. The published range across studies is roughly 20 to 40 percent. The arithmetic above is calibrated to put a useful number in the room at the pharmacy counter; your pharmacist may adjust the dose against their own clinical judgement, and they should.